Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

66 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Management of sialorrhoea in motor neuron disease: a survey of current UK practice.
Hobson EV, McGeachan A, Al-Chalabi A, Chandran S, Crawley F, Dick D, Donaghy C, Ealing J, Ellis CM, Gorrie G, Hanemann CO, Harrower T, Jung A, Majeed T, Malaspina A, Morrison K, Orrell RW, Pall H, Pinto A, Talbot K, Turner MR, Williams TL, Young CA, Shaw PJ, McDermott CJ. Hobson EV, et al. Among authors: harrower t. Amyotroph Lateral Scler Frontotemporal Degener. 2013 Dec;14(7-8):521-7. doi: 10.3109/21678421.2013.790452. Epub 2013 May 7. Amyotroph Lateral Scler Frontotemporal Degener. 2013. PMID: 23647474
Prevalence of depression in amyotrophic lateral sclerosis/motor neuron disease: multi-attribute ascertainment and trajectories over 30 months.
Young CA, Ealing J, McDermott CJ, Williams TL, Al-Chalabi A, Majeed T, Talbot K, Harrower T, Faull C, Malaspina A, Annadale J, Mills RJ, Tennant A; Tonic Study Group. Young CA, et al. Among authors: harrower t. Amyotroph Lateral Scler Frontotemporal Degener. 2023 Feb;24(1-2):82-90. doi: 10.1080/21678421.2022.2096410. Epub 2022 Sep 6. Amyotroph Lateral Scler Frontotemporal Degener. 2023. PMID: 36066075
Measuring quality of life in ALS/MND: validation of the WHOQOL-BREF.
Young CA, Mills R, Al-Chalabi A, Burke G, Chandran S, Dick DJ, Ealing J, Hanemann CO, Harrower T, Mcdermott CJ, Majeed T, Pinto A, Talbot K, Walsh J, Williams TL, Tennant A; TONiC study group. Young CA, et al. Among authors: harrower t. Amyotroph Lateral Scler Frontotemporal Degener. 2020 Jun 27:1-9. doi: 10.1080/21678421.2020.1752244. Online ahead of print. Amyotroph Lateral Scler Frontotemporal Degener. 2020. PMID: 32597226
Measuring disability in amyotrophic lateral sclerosis/motor neuron disease: the WHODAS 2.0-36, WHODAS 2.0-32, and WHODAS 2.0-12.
Young CA, Ealing J, McDermott CJ, Williams TL, Al-Chalabi A, Majeed T, Talbot K, Harrower T, Faull C, Malaspina A, Annadale J, Mills RJ, Tennant A; TONiC Study Group. Young CA, et al. Among authors: harrower t. Amyotroph Lateral Scler Frontotemporal Degener. 2023 Feb;24(1-2):63-70. doi: 10.1080/21678421.2022.2102926. Epub 2022 Jul 23. Amyotroph Lateral Scler Frontotemporal Degener. 2023. PMID: 35876069
A multicentre evaluation of oropharyngeal secretion management practices in amyotrophic lateral sclerosis.
McGeachan AJ, Hobson EV, Al-Chalabi A, Stephenson J, Chandran S, Crawley F, Dick D, Donaghy C, Ellis CM, Gorrie G, Hanemann CO, Harrower T, Jung A, Malaspina A, Morrison KE, Orrell RW, Talbot K, Turner MR, Williams TL, Young CA, Shaw PJ, McDermott CJ. McGeachan AJ, et al. Among authors: harrower t. Amyotroph Lateral Scler Frontotemporal Degener. 2017 Feb;18(1-2):1-9. doi: 10.1080/21678421.2016.1221433. Epub 2016 Aug 31. Amyotroph Lateral Scler Frontotemporal Degener. 2017. PMID: 27579520 Free article.
The relationships between symptoms, disability, perceived health and quality of life in amyotrophic lateral sclerosis/motor neuron disease.
Young CA, Ealing J, McDermott C, Williams T, Al-Chalabi A, Majeed T, Burke G, Pinto A, Dick D, Talbot K, Harrower T, Walsh J, Chandran S, Hanemann CO, Mills R, Tennant A. Young CA, et al. Among authors: harrower t. Amyotroph Lateral Scler Frontotemporal Degener. 2019 Aug;20(5-6):317-327. doi: 10.1080/21678421.2019.1615951. Epub 2019 May 22. Amyotroph Lateral Scler Frontotemporal Degener. 2019. PMID: 31116037
Development and validation of Spasticity Index-Amyotrophic Lateral Sclerosis.
Milinis K, Tennant A, Mills RJ, Al-Chalabi A, Burke G, Dick DJ, Ealing J, Hanemann CO, Harrower T, McDermott CJ, Majeed T, Pinto A, Talbot K, Williams T, Young CA; TONiC study group. Milinis K, et al. Among authors: harrower t. Acta Neurol Scand. 2018 Jul;138(1):47-54. doi: 10.1111/ane.12910. Epub 2018 Feb 21. Acta Neurol Scand. 2018. PMID: 29468643
Measuring coping in people with amyotrophic lateral sclerosis using the Coping Index-ALS: A patient derived, Rasch compliant scale.
Young CA, McDermott CJ, Williams TL, Ealing J, Majeed T, Al-Chalabi A, Dick DJ, Talbot K, Harrower T, Pinto A, Hanemann CO, Burke G, Roberts R, Mills RJ, Tennant A; TONiC study group. Young CA, et al. Among authors: harrower t. J Neurol Sci. 2021 Feb 15;421:117285. doi: 10.1016/j.jns.2020.117285. Epub 2020 Dec 29. J Neurol Sci. 2021. PMID: 33385753
The four self-efficacy trajectories among people with multiple sclerosis: Clinical associations and implications.
Young CA, Mills R, Langdon D, Sharrack B, Majeed T, Kalra S, Footitt D, Rog D, Harrower T, Nicholas R, Woolmore J, Thorpe J, Hanemann CO, Ford H, Paling D, Ellis C, Palace J, Constantinescu C, Tennant A. Young CA, et al. Among authors: harrower t. J Neurol Sci. 2022 May 15;436:120188. doi: 10.1016/j.jns.2022.120188. Epub 2022 Feb 18. J Neurol Sci. 2022. PMID: 35303502
66 results